ClinicalTrials.Veeva
Menu

Find clinical trials for Lymphoma in San Francisco, CA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Non-Hodgkin Lymphoma
B-Cell Lymphoma
Diffuse Large B-Cell Lymphoma
Precursor Cell Lymphoblastic Leukemia-Lymphoma
B-Cell Chronic Lymphocytic Leukemia
Follicular Lymphoma
Leukemia

Lymphoma trials near San Francisco, CA, USA:

Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma

in participants with relapsed/refractory (R/R) peripheral T-cell lymphoma not otherwise specified (PTCL-NOS), follicular helper T-cell lymphomas...

Enrolling
Lymphoma, T-Cell
Nodal Peripheral T-Cell Lymphoma With TFH Phenotype
Drug: Pralatrexate
Drug: Belinostat

Phase 3

Corvus Pharmaceuticals
Corvus Pharmaceuticals

San Francisco, California, United States and 26 other locations

This research is being done to see if epcoritamab is effective in treating follicular lymphoma as a second line of treatment.The name of the...

Enrolling
Lymphoma,Non-Hodgkin
Follicular Lymphoma
Drug: Epcoritamab

Phase 2

Beth Israel Lahey Health
Beth Israel Lahey Health

Stanford, California, United States and 2 other locations

of TLN-121 as a single agent and in combination with other anti-lymphoma therapies in patients with relapsed or refractory Non-Hodgkin Lymphomas...

Enrolling
Lymphoma
Lymphoma, Non Hodgkin
Drug: TLN-254
Drug: TLN-121

Phase 1

Treeline Biosciences, Inc.

Palo Alto, California, United States and 11 other locations

This is a phase II study using risk and response-adapted therapy for low, intermediate and high risk classical Hodgkin lymphoma. Chemotherap...

Active, not recruiting
Hodgkin Lymphoma
Drug: Etoposide
Drug: DTIC

Phase 2

St. Jude Children's Research Hospital
St. Jude Children's Research Hospital

Palo Alto, California, United States and 7 other locations

primary purpose of this study is to evaluate the anti-tumor activity of TLN-254 monotherapy in participants with relapsed or refractory T-cell lymphoma...

Enrolling
Lymphoma
Drug: TLN-254

Phase 1

Treeline Biosciences, Inc.

Stanford, California, United States and 4 other locations

in patients with relapsed central nervous system (CNS) lymphoma. This is the first study to examine a naked anti-CD19 monoclonal antibody in...

Enrolling
CNS Lymphoma
Primary Central Nervous System Lymphoma
Drug: Tafasitamab
Drug: Lenalidomide

Phase 1, Phase 2

James Rubenstein

San Francisco, California, United States

This study will characterize the safety and clinical benefit of valemetostat tosylate in participants with relapsed/refractory peripheral T-cell lymphoma...

Active, not recruiting
Relapsed/Refractory Peripheral T-Cell Lymphoma
Adult T Cell Leukemia/Lymphoma
Drug: Valemetostat Tosylate

Phase 2

Daiichi Sankyo
Daiichi Sankyo

San Francisco, California, United States and 59 other locations

with acute lymphoblastic leukemia (ALL) and acute lymphoblastic lymphoma (LLy).Primary Therapeutic Objectives:* To improve the event-free su...

Active, not recruiting
Acute Lymphoblastic Lymphoma
Acute Lymphoblastic Leukemia
Drug: Asparaginase Erwinia chrysanthemi (recombinant)-rywn
Drug: Thioguanine

Phase 2, Phase 3

St. Jude Children's Research Hospital
St. Jude Children's Research Hospital

Palo Alto, California, United States and 7 other locations

to assess the efficacy and safety of golcadomide in combination with rituximab in participants with newly diagnosed advanced stage Follicular Lymphoma...

Active, not recruiting
Lymphoma, Follicular
Drug: Golcadomide
Drug: Doxorubicin

Phase 2

Celgene
Celgene

San Francisco, California, United States and 56 other locations

RADAR is a multicentre, international, randomised, open-label phase III clinical trial composed of 2 trials running in parallel. Trial 1 will be led...

Enrolling
Hodgkin Lymphoma
Drug: Vinblastine
Drug: Dacarbazine

Phase 3

University College London (UCL)
University College London (UCL)

Stanford, California, United States and 69 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems